Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Veracyte Inc (NASDAQ:VCYT)

5.60
Delayed Data
As of Feb 12
 +0.27 / +5.07%
Today’s Change
4.59
Today|||52-Week Range
12.47
-22.22%
Year-to-Date
No recent news for Veracyte Inc.

Today’s Trading

Previous close5.33
Today’s open5.41
Day’s range5.31 - 5.62
Volume77,297
Average volume (3 months)85,433
Market cap$154.9M
Dividend yield--
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)+77.89%
Earnings growth (this year)+4.09%
Earnings growth (next 5 years)--
Revenue growth (last year)+74.51%
P/E ratioNM
Price/Sales5.47
Price/Book3.05

Competitors

 Today’s
change
Today’s
% change
BDSIBioDelivery Sciences...+0.02+0.57%
TROVTrovagene Inc-0.15-3.84%
QTNTQuotient Ltd+0.60+8.12%
CALACalithera Bioscience...+0.29+6.05%
Data as of 4:00pm ET, 02/12/2016

Financials

Next reporting dateMarch 17, 2016
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$38.2M
Annual profit (last year)-$29.4M
Net profit margin-76.91%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Bonnie H. Anderson
Chief Operating Officer
Christopher M. Hall
Corporate headquarters
South San Francisco, California

Forecasts

Partner Offers